|
|
| | 4A-MPLA Basic information |
| | 4A-MPLA Chemical Properties |
| storage temp. | -20°C | | form | powder | | Major Application | vaccine development | | InChIKey | KREAPURBNFKEHO-BNSRHSNQSA-N |
| WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids |
| | 4A-MPLA Usage And Synthesis |
| Uses | vaccine development | | Biological Activity | Structural modification of diphosphoryl lipid A by hydrolysis produces MPLA (monophosphoryl lipid A) and is known to decrease its toxicity. MPLA, a lipopolysaccharide derivative, acts an immunomodulator and is non-toxic. For this reason, it is useful as a vaccine adjuvant. The MPLA induced immune response is tissue specific. It enhances hostμs resistance against endotoxin induced effects. It also decreases cytokine production during infection. |
| | 4A-MPLA Preparation Products And Raw materials |
|